Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Burman

Showing results (201-210 of 219) with videos related to

Pageof 22
Sort By:
Nature Communications|October 16, 2024
All-optical reporting of inhibitory receptor driving force in the nervous systemJoshua S Selfe, Teresa J S Steyn, Eran F Shorer, et al.
Antiviral Therapy|May 29, 2008
Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trialAndrew N Phillips, Andrew Carr, Jacquie Neuhaus, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 17, 2013
Requirements for the clinical evaluation of new anti-tuberculosis agents in childrenP R Donald, A Ahmed, W J Burman, et al.
Archives of Internal Medicine|March 2, 2011
Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscessTimothy C Jenkins, Bryan C Knepper, Allison L Sabel, et al.
Pharmacotherapy|June 5, 2007
Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infectionDebra A Benator, Marc H Weiner, William J Burman, et al.
Bone Marrow Transplantation|November 12, 2014
Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP)E Snarski, J A Snowden, M C Oliveira, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2022
Precision medicine for developmental and epileptic encephalopathies in Africa-strategies for a resource-limited settingAlina I Esterhuizen, Nicki Tiffin, Gillian Riordan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2013
Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosisRituparna Das, Mi-Sun Koo, Bae Hoon Kim, et al.
Brain : a Journal of Neurology|September 26, 2019
Excitatory GABAergic signalling is associated with benzodiazepine resistance in status epilepticusRichard J Burman, Joshua S Selfe, John Hamin Lee, et al.
Journal of the Pediatric Infectious Diseases Society|December 2, 2015
Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis InfectionMarc Weiner, Radojka M Savic, William R Mac Kenzie, et al.
Pageof 22

Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
Nature Communications|October 16, 2024
All-optical reporting of inhibitory receptor driving force in the nervous systemJoshua S Selfe, Teresa J S Steyn, Eran F Shorer, et al.
Antiviral Therapy|May 29, 2008
Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trialAndrew N Phillips, Andrew Carr, Jacquie Neuhaus, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 17, 2013
Requirements for the clinical evaluation of new anti-tuberculosis agents in childrenP R Donald, A Ahmed, W J Burman, et al.
Archives of Internal Medicine|March 2, 2011
Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscessTimothy C Jenkins, Bryan C Knepper, Allison L Sabel, et al.
Pharmacotherapy|June 5, 2007
Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infectionDebra A Benator, Marc H Weiner, William J Burman, et al.
Bone Marrow Transplantation|November 12, 2014
Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP)E Snarski, J A Snowden, M C Oliveira, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2022
Precision medicine for developmental and epileptic encephalopathies in Africa-strategies for a resource-limited settingAlina I Esterhuizen, Nicki Tiffin, Gillian Riordan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2013
Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosisRituparna Das, Mi-Sun Koo, Bae Hoon Kim, et al.
Brain : a Journal of Neurology|September 26, 2019
Excitatory GABAergic signalling is associated with benzodiazepine resistance in status epilepticusRichard J Burman, Joshua S Selfe, John Hamin Lee, et al.
Journal of the Pediatric Infectious Diseases Society|December 2, 2015
Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis InfectionMarc Weiner, Radojka M Savic, William R Mac Kenzie, et al.
Pageof 22